Long-term outcome of patients with American Joint Committee on Cancer Stage IIB extremity soft tissue sarcomas

Journal of Clinical Oncology

Volumn 17, Issue 9, 1999, Pages 2772-2780

  Fleming, Jason B ^a   Berman, Russell S ^a   Cheng, Su Chun ^a   Chen, Nancy P ^a   Hunt, Kelly K ^a   Feig, Barry W ^a   Respondek, Paula M ^a   Yasko, Alan W ^a   Pollack, Alan ^a   Patel, Shreyaskumar R ^a   Burgess, Michael A ^a   Papadopoulos, Nicholas E ^a   Plager, Carl ^a   Zagars, Gunar ^a   Benjamin, Robert S ^a   Pollock, Raphael E ^a   Pisters, Peter W T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SOFT TISSUE SARCOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032855729     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.9.2772     Document Type: Article

References (24)

1. Gaynor JJ, Tan CC, Casper ES, et al: Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 10:1317-1329, 1992
2. Coindre JM, Terrier P, Bui NB, et al: Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14:869-877, 1996
3. Pisters PWT, Leung DHY, Woodruff J, et al: Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679-1689, 1996
4. Geer RJ, Woodruff J, Casper ES, et al: Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg 127:1285-1289, 1992
5. Lewis JJ, Leung DHY, Casper ES, et al: Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg 134:190-194, 1999
6. American Joint Committee on Cancer: Soft tissue sarcoma, in Fleming ID, Cooper JS, Henson DE, et al (eds): American Joint Committee on Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, pp 149-156
7. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Greenwood M: The natural duration of cancer. Rep Public Health Med Subj 33:1-26, 1926
9. Gelman R, Gelber RD, Henderson IC, et al: Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8:548-555, 1990
10. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
11. Heslin MJ, Woodruff J, Brennan MF: Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: Implications for management. J Clin Oncol 14:473-478, 1996
12. Gustafson P, Dreinhofer KE, Rydholm A: Soft tissue sarcoma should be treated at a tumor center: A comparison of quality of surgery in 375 patients. Acta Orthop Scand 65:47-50, 1994
13. Clasby R, Tilling K, Smith MA, et al: Variable management of soft tissue sarcoma: Regional audit with implications for specialist care. Br J Surg 84:1692-1696, 1997
14. Yang JC, Chang AE, Baker AR, et al: A randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197-203, 1998
15. Pisters PWT, Harrison LB, Leung DHY, et al: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859-868, 1996
16. Pisters PWT, Patel SR, Varma DGK, et al: Preoperative chemotherapy for stage IIB extremity soft tissue sarcoma: Long-term results from a single institution. J Clin Oncol 15:3481-3487, 1997
17. Tierney JF: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 350:1647-1654, 1997
18. Stinson SF, Delaney TF, Greenberg J, et al: Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys 21:1493-1499, 1991
19. Chang AE, Steinberg SM, Culnane M, et al: Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas. J Clin Oncol 7:1217-1228, 1989
20. Healey B, Corson JM, Demetri GD, et al: Surgery alone may be adequate treatment for select stage IA-IIIA soft tissue sarcomas. Proc Am Soc Clin Oncol 14:517, 1995 (abstr A1697)
21. Rydholm A, Gustafson P, Rooser B, et al: Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 9:1757-1765, 1991
22. Karakousis CP, Proimakis C, Walsh DL: Primary soft tissue sarcoma of the extremities in adults. Br J Surg 82:1208-1212, 1995
23. Pisters PWT: Combined modality treatment of extremity soft tissue sarcomas. Ann Surg Oncol 5:464-472, 1998
24. Respondek P, Pollack A, Feig BW, et al: Prospective trial of conservative surgery and selective use of radiotherapy for AJCC T1 extremity and trunk soft tissue sarcomas. Sarcoma 1:219, 1997 (abstr)